MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-PB-20-0007118
JP Pharma Solutions Private Limited
JP Pharma Solutions Private Limited - pharma in Mohali, Punjab, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹86.08 Cr
▲ 8% YoY
Net profit · FY 2024
₹85.76 Lakh
Net margin 1%
EBITDA · FY 2024
₹1.8 Cr
EBITDA margin 2.1%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹46.15 Lakh
Issued & subscribed
Open charges
₹15.29 Cr
Satisfied ₹12.4 Cr
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
About JP Pharma Solutions Private Limited
Data last updated:
JP Pharma Solutions Private Limited is a private limited company based in Mohali, Punjab, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U52609PB2018PTC048606. Its GSTIN is 03AAECJ3897K1Z7 (Punjab).
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹46.15 Lakh. It is led by directors Inderpreet Kaur and Jagpreet Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.D 28 Phase 1 Mohali, Punjab, India – 160055.
As per the financials filed for FY 2024, the company reported a revenue of ₹86.08 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹85.76 Lakh (net margin 1%) and EBITDA of ₹1.8 Cr (EBITDA margin 2.1%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 103% over five years.
The company is associated with 1 brand: JP Pharma Solutions. As per MCA filings, the company has open charges of ₹15.29 Cr and satisfied charges of ₹12.4 Cr on record. Court records list 28 cases involving the company, including 27 filed by the company and 1 filed against it; 9 cases are pending. The company has 1 deal on record (1 rights issue); the latest was in November 2020. Its 10 peer companies in the same principal business activity (retail trading) are compared by revenue, 5 larger and 5 smaller; the largest is Haryana Land Reclamation and Development Corporation Limited with revenue of ₹86.18 Cr.
JP Pharma Solutions Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-PB-20-0007118).
Company details
CIN U52609PB2018PTC048606
Registration Number 048606
Incorporation Date 01 November 2018
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Medium
Udyam Registration UDYAM-PB-20-0007118
Key People
Inderpreet Kaur Director Jagpreet Singh Director Recognitions & Rankings of JP Pharma Solutions
Contact details
JP Pharma Solutions Private Limited's registered office is in Mohali, Punjab. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No.D 28 Phase 1 Mohali, Punjab, India – 160055
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of JP Pharma Solutions Private Limited, buy the company report.
Comprehensive company report
JP Pharma Solutions Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
JP Pharma Solutions operates one associated brand: JP Pharma Solutions. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers pharmaceutical consulting, formulation, technology transfer, and quality auditing services. | jppharmasolutions.com |
Business activity
The main business activity of JP Pharma Solutions is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of JP Pharma Solutions Private Limited, buy the company report.
Financials of JP Pharma Solutions Private Limited
FY 2025 filings availableJP Pharma Solutions Private Limited reported revenue of ₹86.08 Cr (up 8% YoY) for FY 2024.
Revenue · FY 2024
₹86.08 Cr ▲ 8%
Net profit · FY 2024
₹85.76 Lakh margin 1%
EBITDA · FY 2024
₹1.8 Cr margin 2.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 8%
3 years · compounded
▲ 21%
5 years · compounded
▲ 103%
EBITDA CAGR growth
1 year
▼ 3%
3 years · compounded
▲ 34%
5 years · compounded
▲ 137%
Revenue has grown at a compounded annual rate (CAGR) of 103% over five years, including 8% growth in the latest year. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.8 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹85.76 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.1% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of JP Pharma Solutions Private Limited, buy the company report.
Board of directors of JP Pharma Solutions Private Limited
JP Pharma Solutions has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Inderpreet Kaur | Director | 01 Nov 2018 | 8 Years 0 Months | Current |
| Jagpreet Singh Also directs: Bionial Healthcare Private Limited | Director | 01 Nov 2018 | 8 Years 0 Months | Current |
Peer comparison
JP Pharma Solutions Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Haryana Land Reclamation and Development Corporation Limited | ₹86.18 Cr (FY 2023) | 14.0% | Panchkula, Haryana, India | |||
| D & V Green-Wheels Private Limited | ₹86.18 Cr (FY 2025) | 61.0% | Bangalore, Karnataka, India | |||
| Proline India Limited | ₹86.16 Cr (FY 2020) | 5.0% | Mumbai, Maharashtra, India | |||
| Aatap Trading India Private Limited | ₹86.12 Cr (FY 2019) | 43222.0% | Delhi, India | |||
| BRS Softech Private Limited | ₹86.1 Cr (FY 2025) | 119.0% | New Delhi, Delhi, India | |||
| JP Pharma Solutions Private Limitedthis company | ₹86.08 Cr (FY 2024) | ₹85.76 Lakh | 1% | 8.0% | Mohali, Punjab, India | |
| Naitik Forex Private Limited | ₹86.07 Cr (FY 2023) | 19612.0% | Mumbai, Maharashtra, India | |||
| Richesm Healthcare Limited | ₹86.06 Cr (FY 2024) | 606.0% | Noida, Uttar Pradesh, India | |||
| Axis Motors Private Limited | ₹86.05 Cr (FY 2025) | 29.0% | Kanpur, Uttar Pradesh, India | |||
| DKC Tradex Private Limited. | ₹86.01 Cr (FY 2025) | 24.0% | Delhi, India | |||
| Sids Motors Private Limited | ₹86 Cr (FY 2024) | 32.0% | Rajkot, Gujarat, India |
To see the full peer comparison of JP Pharma Solutions Private Limited, buy the company report.
Auditor
JP Pharma Solutions Private Limited is audited by M DHIMAN & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M DHIMAN & ASSOCIATES | FY 2022 | 023032N |
Shareholding
The shareholding of JP Pharma Solutions Private Limited is on record for 4 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of JP Pharma Solutions Private Limited, buy the company report.
Charges & borrowings
Open charges
₹15.29 Cr
Satisfied charges
₹12.4 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Jun 2025 | 101125649 | Others | ₹30 Lakh | Open | |
| 18 Nov 2024 | 101028134 | Others | ₹17 Lakh | Open | |
| 26 Feb 2024 | 100880595 | Others | ₹14.82 Cr | Open | |
| 29 Jul 2021 | 100474856 | Hdfc Bank Limited | ₹8.4 Cr | Satisfied | |
| 06 May 2019 | 100265359 | Others | ₹4 Cr | Satisfied |
To see the full charge records of JP Pharma Solutions Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
JP Pharma Solutions Private Limited has 1 deal on record (1 rights issue); the latest was in November 2020.
Total deals
1
Rights issue
1
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2020 | Rights issue | ₹1.49 Cr | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
JP Pharma Solutions Private Limited has 28 court cases on record: 27 filed by JP Pharma Solutions, 1 filed against it. 9 cases are pending and 19 are disposed.
Total cases
28
Filed by the company
27
Filed against the company
1
Pending
9
Disposed
19
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 27 | 0 | 9 |
| High courts | 1 | 1 | 0 |
Cases on record (5 of 28)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Court case (COMSS) | Filed against the company by Pfizer Products India Pvt Ltd and 1 other | Disposed |
| District court, Mohali, Punjab | Civil suit | Filed by the company against Pfizer Products India Private Ltd. | Disposed |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against Vrinda Enterprises | Pending |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against A.D Pharmacy | Pending |
To see the full case history of JP Pharma Solutions Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for JP Pharma Solutions Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
JP Pharma Solutions has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAECJ3897K1Z7 | Punjab | Active | 01 Feb 2019 |
To see the full GST registrations and return filing status of JP Pharma Solutions Private Limited, buy the company report.
Recent activity
JP Pharma Solutions Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Inderpreet Kaur was appointed as Director on 01 Nov 2018.
AGM
Jp Pharma Solutions Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 0.30 Cr with Charge ID 101125649 was registered on 20 Jun 2025.
Filing
Jp Pharma Solutions Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Charges
A charge with Others of Rs. 14.82 Cr registered on 26 Feb 2024 with Charge ID 100880595 was modified on 04 Jan 2025.
Charges
A charge with Others amounted to Rs. 0.17 Cr with Charge ID 101028134 was registered on 18 Nov 2024.
Charges
A charge registered on 29 Jul 2021 via Charge ID 100474856 with Hdfc Bank Limited was fully satisfied on 06 Apr 2024.
Charges
A charge with Others amounted to Rs. 14.82 Cr with Charge ID 100880595 was registered on 26 Feb 2024.
Charges
A charge with Hdfc Bank Limited of Rs. 8.40 Cr registered on 29 Jul 2021 with Charge ID 100474856 was modified on 22 Nov 2022.
Charges
A charge registered on 06 May 2019 via Charge ID 100265359 with Others was fully satisfied on 27 Aug 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 8.40 Cr with Charge ID 100474856 was registered on 29 Jul 2021.
Charges
A charge with Others amounted to Rs. 4.00 Cr with Charge ID 100265359 was registered on 06 May 2019.
Appointed
Inderpreet Kaur was appointed as Director.
2 earlier events are in the company report.
Frequently asked questions
JP Pharma Solutions is an active private limited company based in Mohali, Punjab, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 November 2018 (8+ years old) and is registered under CIN U52609PB2018PTC048606.
JP Pharma Solutions has 2 current directors:
- Inderpreet Kaur - Director
- Jagpreet Singh - Director
The latest financial statements of JP Pharma Solutions on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of JP Pharma Solutions is 03AAECJ3897K1Z7, registered in Punjab.
The CIN (Corporate Identification Number) of JP Pharma Solutions is U52609PB2018PTC048606. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
JP Pharma Solutions has 28 court cases on record: 27 filed by the company and 1 filed against it. 9 are pending. Most are in the district courts.
JP Pharma Solutions was incorporated on 01 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chandigarh.
JP Pharma Solutions has 1 deal on record (1 rights issue); the latest was in November 2020.
The peers of JP Pharma Solutions by revenue are Haryana Land Reclamation and Development Corporation Limited, D & V Green-Wheels Private Limited, Proline India Limited, Aatap Trading India Private Limited, BRS Softech Private Limited and 5 more, all in the same principal business activity (retail trading).
Inderpreet Kaur was appointed as Director on 01 Nov 2018. Jagpreet Singh was appointed as Director on 01 Nov 2018.
Yes, JP Pharma Solutions is registered as a medium enterprise under Udyam registration (number: UDYAM-PB-20-0007118).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages